Dr. Melissa A. Harbit, MD

Dr. Harbit practices at Washington University School of Medicine in Saint Louis, Missouri.

Dr. Harbit's NPI, 1295751410, was assigned on July 14, 2006. Dr. Harbit graduated from Carver College of Medicine in 1997. Dr. Harbit holds Missouri license 2002004013.

Dr. Harbit's primary practice is Washington University School of Medicine, at 216 S Kingshighway Blvd, Saint Louis, MO 63110 in Saint Louis City. The practice phone is (314) 362-5184.

Dr. Harbit's primary practice is Washington University School of Medicine in Saint Louis, Missouri. Dr. Harbit is also affiliated with Barnes-Jewish Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Harbit to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Harbit practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Harbit's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Harbit is board certified in forensic psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Harbit's licenses on file in 3 states: Missouri, Florida and New York.

Dmand AI lists bipolar disorder, depression, schizophrenia and tobacco use among the conditions Dr. Harbit treats.

CMS data shows 55 Medicare services from Dr. Harbit across 2 procedure codes in 2024, for 22 Medicare patients. Medicare paid $4,151 for them. Every service was in an office.

CMS counts 22 Medicare patients who saw Dr. Harbit in 2024. The largest group is 65 to 74, with 11 patients. 75% of them have mood disorders, and 73% have high cholesterol. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Harbit's median patient age at 71, with 71% women.

In 2024, Dr. Harbit wrote 385 Medicare Part D claims for 35 patients. 100% of them were for generic drugs. CMS names the drug for 317 of them, across 16 drugs with 11 or more claims each, at $3,969 in total drug cost. In 2023, CMS named 223 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Harbit for performance year 2024, reported as part of a group. Dr. Harbit accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Harbit as offering telehealth.

Dmand AI links 2 papers to Dr. Harbit. Dr. Harbit's most frequent co-authors are Nuri Bradford Farber, MD and William Jarred Newman, MD.

Dmand AI lists 1 award for Dr. Harbit, most recently CMS Stage 1 EHR in 2012.

Dr. Harbit graduated from Carver College of Medicine in 1997.

Dr. Harbit is in network with 11 carriers, including Aetna, United Healthcare and Elevance. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.